Although previous studies have observed that Black patients are less likely to receive kidney transplants than White patients, the points of inequity in the transplant process were unclear.
Among respondents to a 2019 survey of US transplant program staff, 42% reported that they do not accept HCV-viremic kidneys for uninfected transplant candidates.
ChemoCentryx, Inc has submitted a NDA to the Food and Drug Administration (FDA) for acavopan in the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
In separate COVID-19 studies, investigators found that only some infected kidney transplant outpatients required hospitalization and patients on maintenance hemodialysis often have an atypical presentation of symptoms.
